| Antibiotic research and development: business as usual? HJ Harbarth S, Theuretzbacher U J Antimicrob Chemother., 2015 | 114 | 2015 |
| Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure M Stanić Benić, R Milanič, AA Monnier, IC Gyssens, N Adriaenssens, ... Journal of antimicrobial chemotherapy 73 (suppl_6), vi50-vi58, 2018 | 112 | 2018 |
| Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure M Le Maréchal, G Tebano, AA Monnier, N Adriaenssens, IC Gyssens, ... Journal of Antimicrobial Chemotherapy 73 (suppl_6), vi40-vi49, 2018 | 74 | 2018 |
| Patient-related determinants of antibiotic use: a systematic review V Zanichelli, G Tebano, IC Gyssens, V Vlahović-Palčevski, AA Monnier, ... Clinical microbiology and infection 25 (1), 48-53, 2019 | 73 | 2019 |
| Variation in antibiotic use among and within different settings: a systematic review V Zanichelli, AA Monnier, IC Gyssens, N Adriaenssens, A Versporten, ... Journal of Antimicrobial Chemotherapy 73 (suppl_6), vi17-vi29, 2018 | 65 | 2018 |
| Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure AA Monnier, J Schouten, M Le Maréchal, G Tebano, C Pulcini, ... Journal of antimicrobial chemotherapy 73 (suppl_6), vi30-vi39, 2018 | 61 | 2018 |
| Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure. GIC Monnier AA1, Eisenstein BI, Hulscher ME J Antimicrob Chemother. 73, (suppl_6):vi3-vi16, 2018 | 53* | 2018 |
| Potentially inappropriate prescribing in elderly outpatients in Croatia B Popović, N Radošević Quadranti, S Mimica Matanović, D Pezelj Duliba, ... EURODURG scientific meeting, 2014 | 43 | 2014 |
| Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure A Versporten, IC Gyssens, C Pulcini, AA Monnier, J Schouten, R Milanič, ... Journal of antimicrobial chemotherapy 73 (suppl_6), vi59-vi66, 2018 | 41 | 2018 |
| The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients T Zekić, MS Benić, R Antulov, I Antončić, S Novak Rheumatology international 37, 2105-2114, 2017 | 20 | 2017 |
| CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol-induced extrapyramidal symptoms I Šimić, I Potočnjak, I Kraljičković, M Stanić Benić, I Čegec, D Juričić Nahal, ... Pharmacogenomics 17 (13), 1385-1389, 2016 | 10 | 2016 |
| Infekcije u dijalizi i transplantaciji bubrega M STANIĆ, K MIHOVILOVIĆ, M KNOTEK Acta medica Croatica: Časopis Akademije medicinskih znanosti Hrvatske 69 (3 …, 2015 | 10 | 2015 |
| Views and experiences with regard to antibiotic use of hospitalized patients in five European countries: a qualitative descriptive study V Zanichelli, AA Monnier, G Tebano, BM Stanić, IC Gyssens, C Pulcini, ... Clinical microbiology and infection 25 (2), 249. e7-249. e12, 2019 | 8 | 2019 |
| Postantimikrobni proljev i bolest povezana s Clostridium difficile: opservacijsko retrospektivno istraživanje u Klinici za infektivne bolesti "Dr. Fran Mihaljević" u Zagrebu R Čivljak, S Bukovski, I Bambir, M Stanić, L Torić, S Sović, M Dumančić, ... Infektolo{ki glasnik 34 (3), 133–143, 2014 | 7 | 2014 |
| Repeated point prevalence survey on antimicrobial use in a university hospital: what have we learned? A Belančić, M Stanić Benić, N Skočibušić, D Palčevski, ... International journal of pharmacy practice 29 (4), 362-368, 2021 | 5 | 2021 |
| Clindamycin-induced necrotising oesophagitis M Stanić Benić, K Karlović, A Čubranić Postgraduate medical journal 92 (1094), 741-741, 2016 | 4 | 2016 |
| Dijagnostičko-terapijski pristup pacijentu sa sumnjom na alergiju na penicilin M Stanić Benić, V Vlahović-Palčvevski Medicina Fluminensis: Medicina Fluminensis 52 (1), 28-36, 2016 | 4 | 2016 |
| Does Fluoroquinolones and Third-Generation Cephalosporins Restriction Reverse Extended-Spectrum β-Lactamases Klebsiella pneumoniae Resistance Rates? D Palčevski, R Milanič, N Skočibušić, M Abram, V Vlahović-Palčevski Microbial Drug Resistance (Larchmont, NY) 27 (9), 1159-1166, 2021 | 1 | 2021 |
| The impact of biological interventions on health‐related quality of life in adults with Crohn's disease MS Benic, V Giljaca, V Vlahovic‐Palcevski The Cochrane Database of Systematic Reviews 2018 (2), 2018 | 1 | 2018 |
| Trend of biosimilars prescribing in a Croatian teaching hospital MS Benic, S Jakovac, T Zekic, V Vlahovic-Palcevski Clinical Therapeutics 38 (10), e28, 2016 | 1 | 2016 |
Vera Vlahović-PalčevskiMedicinski fakultet Sveučilišta u Rijeci, Klinički bolnički centar RijekaVerified email at medri.uniri.hr
